Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tetrahydrouridine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase II Combination Chemotherapy with ARA-C/Tetrahydrouridine for Patients with Chronic Myelocytic Leukemia in Blast Crisis
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7851
Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 21
Sponsor: NCI, Other
Protocol IDs: UMIAMI-20020154, SCCC-2002033, NCI-6301, 6301, NCT00077051
Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: 20057104, SCCC-2005097, WIRB-20051340, EPROST-20057104, SCCC-EPROST-20057104, SCCC-WIRB-20051340, NCT00521183
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09045, NCI-2009-01661, NCT01041443
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 98127, PHI-16, UM1CA62505, NCI-2015-00655, 06-C-0221, NCT00359606
Imaging Study for FdCyd and THU Cancer Treatment
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Enrolling by invitation
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120014, 12-C-0014, NCT01479348
Start Over